Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG).

Autor: Akyildiz A; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. drakyildizarif@gmail.com., Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Koksal B; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Karaoglan BB; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kivrak D; Department of Medical Oncology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey., Ismayilov R; Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey., Aslan F; Department of Medical Oncology, Ankara Medical Park Hospital, Ankara, Turkey., Sutcuoglu O; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey., Yazici O; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey., Kadioglu A; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Alan O; Department of Medical Oncology, Koç University, Istanbul, Turkey., Majidova N; Department of Medical Oncology, Marmara University, Pendik Training and Research Hospital, Istanbul, Turkey., Erciyestepe M; Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Ozcan E; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey., Akdag G; Department of Medical Oncology, University of Health Science, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Taban H; Department of Medical Oncology, Samsun Training and Research Hospital, Samsun, Turkey., Kaya AO; Department of Medical Oncology, Biruni University Faculty of Medicine, Istanbul, Turkey., Guliyev M; Department of Medical Oncology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey., Yildirim N; Department of Medical Oncology, Firat University Faculty of Medicine, Elazig, Turkey., Sakalar T; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey., Yazilitas D; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey., Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey., On S; Department of Oncology, Ege University Faculty of Medicine, Izmir, Turkey., Biter S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Demirci NS; Department of Medical Oncology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey., Senler FC; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kemal Y; Department of Medical Oncology, Altinbas University Faculty of Medicine, Samsun, Turkey., Halil OD; Department of Medical Oncology, Near East University Hospital, Nicosia, Cyprus., Gullu I; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Sep; Vol. 281 (9), pp. 4991-4999. Date of Electronic Publication: 2024 May 25.

Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma.

Autor: Erul E; Department of Internal Medicine, Hacettepe University, Ankara, 06230, Turkey., Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06230, Turkey., Ozbay Y; Department of Radiology, Hacettepe University, Ankara, 06230, Turkey., Altunbulak AY; Department of Radiology, Hacettepe University, Ankara, 06230, Turkey., Kahvecioglu A; Department of Radiation Oncology, Hacettepe University, Ankara, 06230, Turkey., Ercan F; Department of Internal Medicine, Hacettepe University, Ankara, 06230, Turkey., Yesil MF; Department of Internal Medicine, Hacettepe University, Ankara, 06230, Turkey., Ucdal MT; Department of Internal Medicine, Hacettepe University, Ankara, 06230, Turkey., Cengiz M; Department of Radiation Oncology, Hacettepe University, Ankara, 06230, Turkey., Yazici G; Department of Radiation Oncology, Hacettepe University, Ankara, 06230, Turkey., Kuscu O; Department of Otorhinolaryngology & Head & Neck Surgery, Hacettepe University, Ankara, 06230, Turkey., Suslu N; Department of Otorhinolaryngology & Head & Neck Surgery, Hacettepe University, Ankara, 06230, Turkey., Gullu I; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06230, Turkey., Onur MR; Department of Radiology, Hacettepe University, Ankara, 06230, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06230, Turkey.

Publikováno v: Biomarkers in medicine [Biomark Med] 2023 Jan; Vol. 17 (2), pp. 87-99. Date of Electronic Publication: 2023 Apr 12.

Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience.

Autor: Sari SY; Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey. Electronic address: sezin_yuce@hotmail.com., Yilmaz MT; Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey. Electronic address: mlktgcylmz@gmail.com., Aktas BY; Department of Medical Oncology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey. Electronic address: byaktas@hacettepe.edu.tr., Aksoy S; Department of Medical Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey. Electronic address: saksoy@hacettepe.edu.tr., Gullu I; Department of Medical Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey. Electronic address: ibrahimhalil.gullu@hacettepe.edu.tr., Cengiz M; Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey. Electronic address: mcengiz@hacettepe.edu.tr., Ozyigit G; Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey. Electronic address: gozyigit@hacettepe.edu.tr., Yazici G; Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey. Electronic address: yazicig@gmail.com.

Publikováno v: Oral oncology [Oral Oncol] 2022 Jan; Vol. 124, pp. 105658. Date of Electronic Publication: 2021 Dec 06.

Cancer incidence in Behçet's disease.

Autor: Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, 06100 Sıhhıye, Ankara, Turkey. denizcguven@hotmail.com., Bolek EC; Department of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Altintop SE; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Celikten B; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Aktas BY; Department of Medical Oncology, Hacettepe University Cancer Institute, 06100 Sıhhıye, Ankara, Turkey., Kiraz S; Department of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Gullu İ; Department of Medical Oncology, Hacettepe University Cancer Institute, 06100 Sıhhıye, Ankara, Turkey., Karadag O; Department of Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Dizdar O; Department of Medical Oncology, Hacettepe University Cancer Institute, 06100 Sıhhıye, Ankara, Turkey.

Publikováno v: Irish journal of medical science [Ir J Med Sci] 2020 Nov; Vol. 189 (4), pp. 1209-1214. Date of Electronic Publication: 2020 May 08.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.